Jon R. Levine is recorded as Board Member at Marimed Inc. (MRMD) since January 1, 2017 and CEO at Marimed Inc. (MRMD). The newest filing on record that lists Jon R. Levine as CEO and Board Member at Marimed Inc. (MRMD) is dated April 23, 2026. Marimed Inc. reported in an 8-K filed November 3, 2023 that Jon R. Levine was appointed Interim Chief Financial Officer, effective October 31, 2023. The proxy statement of Marimed Inc. reports total compensation of $348,954 for Jon R. Levine in fiscal 2025, including a base salary of $300,000. Disclosed compensation is on record for 6 fiscal years. Jon R. Levine has spoken on 2 earnings calls across 1 company, most recently for Marimed Inc. on November 12, 2026. Marimed Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Marimed Inc. includes Edward Gildea (Chairman), Mario Pinho (CFO), Timothy Shaw (COO) and 2 others.
“The Board of Directors has appointed Jon R. Levine, the Company's President and Chief Executive Officer, as the Company's Interim Chief Financial Officer and has initiated a search process to identify and engage a new Chief Financial Officer.”
Marimed Inc. Form 8-K, filed November 3, 2023
· Read the filing
Jon R. Levine on recent calls
“I'm pleased to report that the momentum we built earlier this year continues through the third quarter. We generated the highest quarterly revenue in our history, with growth in both wholesale and retail, sequentially and year-over-year.”
“The second quarter represented meaningful progress for Merriment. Revenue increased in both our wholesale and retail businesses, both sequentially and year-over-year, resulting in the highest quarterly revenue in our history.”
